17689017|t|22R-Hydroxycholesterol induces differentiation of human NT2 precursor (Ntera2/D1 teratocarcinoma) cells.
17689017|a|Recently, we have shown that 22R-hydroxycholesterol, a steroid intermediate in the pathway of pregnenolone formation from cholesterol, is present at lower levels in Alzheimer's disease (AD) hippocampus and frontal cortex tissue specimens than in age-matched controls, and that this substance protects against cell death induced by amyloid beta-peptide in both rat sympathetic nerve pheochromocytoma (PC12) and differentiated human Ntera2/D1 teratocarcinoma neurons. Herein we report that 22R-hydroxycholesterol inhibits the proliferation of human Ntera2/D1 teratocarcinoma precursor cells (NT2) and induces these cells to differentiate into "neuron-like" or "astrocyte-like" cells. 22R-Hydroxycholesterol-induced differentiation of NT2 cells is associated with increases in the expression of neurofilament protein NF200, the cytoskeletal proteins microtubule-associated protein type II (MAP2) a and MAP2b, glial fibrillary acidic protein (GFAP) and glial cell line-derived neurotrophic factor receptor-alpha 2 (GFRalpha2). These effects of 22R-hydroxycholesterol are considered to be stereospecific because its enantiomer 22S-hydroxycholesterol and other steroids failed to induce differentiation of NT2 cells. 22R-Hydroxycholesterol was found to lack specific binding for numerous receptors, including all steroid receptors tested. However, using a cholesterol protein binding blot assay we demonstrated the presence of a 22R-hydroxycholesterol-binding protein in NT2 cells distinct from the human oxysterol receptors liver X receptor LXRalpha and beta.
17689017	0	22	22R-Hydroxycholesterol	Chemical	MESH:C003585
17689017	50	55	human	Species	9606
17689017	56	59	NT2	CellLine	CVCL:JA57
17689017	71	96	Ntera2/D1 teratocarcinoma	CellLine	CVCL:3407
17689017	134	156	22R-hydroxycholesterol	Chemical	MESH:C003585
17689017	160	167	steroid	Chemical	MESH:D013256
17689017	199	211	pregnenolone	Chemical	MESH:D011284
17689017	227	238	cholesterol	Chemical	MESH:D002784
17689017	270	289	Alzheimer's disease	Disease	MESH:D000544
17689017	291	293	AD	Disease	MESH:D000544
17689017	465	468	rat	Species	10116
17689017	505	509	PC12	CellLine	CVCL:0481
17689017	530	535	human	Species	9606
17689017	536	561	Ntera2/D1 teratocarcinoma	CellLine	CVCL:3407
17689017	593	615	22R-hydroxycholesterol	Chemical	MESH:C003585
17689017	646	651	human	Species	9606
17689017	652	677	Ntera2/D1 teratocarcinoma	CellLine	CVCL:3407
17689017	695	698	NT2	CellLine	CVCL:JA57
17689017	787	809	22R-Hydroxycholesterol	Chemical	MESH:C003585
17689017	837	840	NT2	CellLine	CVCL:JA57
17689017	992	999	MAP2) a	Gene	4133;126364
17689017	1004	1009	MAP2b	Gene	4133
17689017	1011	1042	glial fibrillary acidic protein	Gene	2670
17689017	1044	1048	GFAP	Gene	2670
17689017	1116	1125	GFRalpha2	Gene	2675
17689017	1145	1167	22R-hydroxycholesterol	Chemical	MESH:C003585
17689017	1227	1249	22S-hydroxycholesterol	Chemical	MESH:C003585
17689017	1260	1268	steroids	Chemical	MESH:D013256
17689017	1305	1308	NT2	CellLine	CVCL:JA57
17689017	1316	1338	22R-Hydroxycholesterol	Chemical	MESH:C003585
17689017	1455	1466	cholesterol	Chemical	MESH:D002784
17689017	1570	1573	NT2	CellLine	CVCL:JA57
17689017	1598	1603	human	Species	9606
17689017	Positive_Correlation	MESH:C003585	2675
17689017	Negative_Correlation	MESH:D013256	MESH:D000544
17689017	Positive_Correlation	MESH:C003585	2670
17689017	Positive_Correlation	MESH:C003585	4133
17689017	Negative_Correlation	MESH:C003585	MESH:D000544
17689017	Positive_Correlation	MESH:C003585	126364

